Sabine Brookman-May, Senior Vice President and Therapeutic Area Head of Urologic Oncology at Aura Biosciences, shared a post on X:
“Elevated CXCR4 expression in MIBC in vitro was the basis for this first patient cohort.
- Ga68 CXCR4 imaging plus RLT with Lu-177 FAP/CXCR4 and systemic ddMVAC
- Pathologic complete response in 5 of 5 patients with MIBC
Great work.”
More posts featuring Sabine Brookman-May.